Offer - Urjas Oil for just ₹ 1 X
Aztrone 1 Injection is a prescription medicine that is available as a Injection. It is primarily used for the treatment of Bacterial Infections, Cystic Fibrosis. Secondary and off-label uses of Aztrone 1 Injection have also been mentioned below.
The optimal dosage of Aztrone 1 Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Aztrone 1 Injection have been listed ahead. Such side effects of Aztrone 1 Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Aztrone 1 Injection has a Safe effect for pregnant women and Safe effect on lactating mothers. It is important to know if Aztrone 1 Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Aztrone 1 Injection related warnings section.
Aztrone 1 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. Other contraindications of Aztrone 1 Injection have been discussed in the sections ahead.
Drug interactions for Aztrone 1 Injection have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Aztrone 1 Injection is considered not safe while driving, and is not addictive.
Aztrone 1 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Aztrone 1 Injection safe for pregnant women?
Aztrone is safe to take during pregnancy.
Is the use of Aztrone 1 Injection safe during breastfeeding?
Breastfeeding women can safely use Aztrone.
What is the effect of Aztrone 1 Injection on the Kidneys?
Aztrone rarely harms the kidneys.
What is the effect of Aztrone 1 Injection on the Liver?
Aztrone does not damage the liver.
What is the effect of Aztrone 1 Injection on the Heart?
Using Aztrone does not have any harmful effects on the heart.
Aztrone 1 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Aztrone 1 Injection unless your doctor advises you to do so -
Is this Aztrone 1 Injection habit forming or addictive?
No, there is no any evidence that Aztrone 1 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Aztrone 1 Injection as you may feel sleepy.
Is it safe?
Aztrone 1 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Aztrone 1 Injection in mental disorders is not effective.
Interaction between Food and Aztrone 1 Injection
Taking Aztrone 1 Injection with food does not harm your health.
Interaction between Alcohol and Aztrone 1 Injection
Information about the interaction of Aztrone 1 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azactam® (aztreonam)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 730